Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma

Zizhen Li,Wenhua Lu,Feng Yin,Peiting Zeng,Heping Li,Amin Huang
DOI: https://doi.org/10.1186/s12967-024-05112-y
IF: 8.44
2024-04-11
Journal of Translational Medicine
Abstract:Lung adenocarcinoma (LUAD), the most common and lethal subtype of lung cancer, continues to be a major health concern worldwide. Despite advances in targeted and immune therapies, only a minority of patients derive substantial benefits. As a result, the urgent need for novel therapeutic strategies to improve lung cancer treatment outcomes remains undiminished.
medicine, research & experimental
What problem does this paper attempt to address?
The problem this paper attempts to address is the exploration of the expression pattern of tumor necrosis factor superfamily member 11 (TNFSF11, also known as RANKL) in lung adenocarcinoma (LUAD) and its relationship with clinicopathological parameters. Furthermore, it investigates the biological function and potential therapeutic targets of TNFSF11 in LUAD. Specifically, the researchers addressed this problem through the following aspects: 1. **Expression Pattern Analysis**: - Used the TIMER database to analyze the expression of TNFSF11 in various cancer types. - Compared the expression levels of TNFSF11 in normal and tumor tissues using the TCGA-LUAD dataset and tissue microarrays. - Conducted external validation using the GSE31210 dataset to confirm the high expression of TNFSF11 in tumor tissues. 2. **Clinical Correlation Analysis**: - Analyzed the relationship between TNFSF11 expression levels and the clinicopathological characteristics of LUAD patients (such as T stage, N stage, M stage, pathological stage, smoking status, etc.). - Evaluated the relationship between high TNFSF11 expression and patient survival through Kaplan-Meier survival curve analysis. 3. **Functional Studies**: - Investigated the function of TNFSF11 in LUAD cells through gene knockdown and overexpression experiments. - Found that TNFSF11 is negatively correlated with GPX4 (glutathione peroxidase 4) and that cells overexpressing TNFSF11 are more sensitive to ferroptosis inducers. 4. **Mechanism Exploration**: - Conducted gene co-expression analysis and KEGG pathway enrichment analysis to reveal the metabolic pathways and peroxisome pathways that TNFSF11 may be involved in. 5. **Therapeutic Potential**: - Evaluated the therapeutic effect of ferroptosis inducers in LUAD cells with high TNFSF11 expression through in vivo and in vitro experiments. In summary, this paper aims to reveal the mechanism of TNFSF11 in LUAD through multi-faceted research, providing a theoretical basis for its potential as a therapeutic target.